P-122 - IMPACT OF CYP3A4, CYP3A5, AND ABCB1 ON ORAL TACROLIMUS (TAC) CONCENTRATIONS WHEN TRANSITIONING FROM CONTINUOUS INFUSION INTRAVENOUS (IV) TO ORAL FORMULATION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (HCT) RECIPIENTS.
S. Morris, E. Jandrisevits, H. Zeng, J. He, S. Hanson, A. Hamilton, N. Steuerwald, J. Patel; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
.jpg "Sarah A. Morris, PharmD photo")
.png)